Celltrion Pharm, Inc.

KOSDAQ 068760.KQ

Celltrion Pharm, Inc. Market Capitalization on January 14, 2025: USD 1.64 B

Celltrion Pharm, Inc. Market Capitalization is USD 1.64 B on January 14, 2025, a -50.34% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Celltrion Pharm, Inc. 52-week high Market Capitalization is USD 3.59 B on February 28, 2024, which is 118.57% above the current Market Capitalization.
Celltrion Pharm, Inc. 52-week low Market Capitalization is USD 1.43 B on December 09, 2024, which is -12.98% below the current Market Capitalization.
Celltrion Pharm, Inc. average Market Capitalization for the last 52 weeks is USD 2.52 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

KOSDAQ: 068760.KQ

Celltrion Pharm, Inc.

CEO	Jung-su Seo
IPO Date	Feb. 3, 2006
Location	South Korea
Headquarters	82, 2sandan-ro
Employees	888
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.

Key trends

Past 5 years